Little information has emerged about osavampator, a potentially first-in-class drug, since its promising Phase II performance last spring.

After leading Japan’s largest drugmaker for 11 years, Takeda CEO Christophe Weber plans to step down in June of 2026. He will ...

Takeda has named Julie Kim as its next CEO. She will replace Christophe Weber who plans to step down in June of 2026 after leading Japan’s largest drugmaker for 11 years. | Takeda has named Julie Kim ...

Japanese drugmaker Takeda’s latest financial results were presented Thursday, though they took a back seat to the news that ...

Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended ...

PersonnelTakeda Pharmaceutical Company Limited: Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 202630-Jan-2025 / 09:31 CET/CESTDisclosure of an inside information acc. to Article 17 ...

Julie Kim, president of the U.S. Business Unit, named to succeed Weber after multi-year succession process ...

USA-based Neurocrine Biosciences yesterday revealed it has amended its agreement with Japanese pharma major Takeda to develop ...

Lasell University president Eric Turner is hoping that many Lasell students will find success in the real world by spending ...

The project consists of developing a 5.8-acre site at 305 Brookline Ave, which is currently the home of Simmons University’s residential campus, to include labs, housing, retail and public space.

Beyond being a big deal for Takeda, which is the state’s largest ... the 16-story tower at 585 Kendall is one of the few major commercial projects underway in Greater Boston right now.